Christopher A. Viehbacher is a German businessperson who founded Boston Pharmaceuticals, Inc. and who has been the head of 11 different companies. Currently, Mr. Viehbacher is Executive Chairman for Boston Pharmaceuticals, Inc., Chairman of PureTech Health Plc, Chairman for Vedanta Biosciences, Inc. and Managing Partner at Gurnet Point Capital LLC. Christopher A. Viehbacher is also on the board of 5 other companies.
He previously occupied the position of Chairman for Pfizer Inc., Chief Executive Officer & Director at Sanofi President for Genzyme Corp. and Chief Executive Officer for Sanofi-Aventis U.S. LLC (both are subsidiaries of Sanofi), Director & Head-Pharmaceuticals Operations at GlaxoSmithKline Plc Chairman & Chief Executive Officer for Glaxo Wellcome Plc and President for GlaxoSmithKline LLC (both are subsidiaries of GlaxoSmithKline Plc), Principal at PricewaterhouseCoopers LLP, Chairman at Pharmaceutical Research & Manufacturers of America, President-Elect at European Federation of Pharmaceutical Industries & Assns, Member of The International Business Council and Member-International Business Council at Forum Mondial de L'Economie.
Christopher A. Viehbacher received an undergraduate degree from Queen's University.